Sfoglia per Autore
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
2024 Mantovani, A; Morieri, M; Aldigeri, R; Palmisano, L; Masulli, M; Bonomo, K; Baroni, M; Cossu, E; Cimini, F; Cavallo, G; Buzzetti, R; Mignogna, C; Leonetti, F; Bacci, S; Trevisan, R; Pollis, R; Cas, A; de Kreutzenberg, S; Targher, G
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy
2024 Lepore, G; Borella, N; Castagna, G; Ippolito, S; Bonfadini, S; Corsi, A; Scaranna, C; Dodesini, A; Bellante, R; Trevisan, R
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
2023 Orsi, E; Solini, A; Bonora, E; Vitale, M; Garofolo, M; Fondelli, C; Trevisan, R; Vedovato, M; Cavalot, F; Zerbini, G; Nicolucci, A; Pugliese, G
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality
2023 Ciardullo, S; Dodesini, A; Lepore, G; Corsi, A; Scaranna, C; Perseghin, G; Trevisan, R
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System
2023 Dodesini, A; Borella, N; Lepore, G; Corsi, A; Bonfadini, S; Bellante, R; Scaranna, C; Trevisan, R
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
2023 Csermely, A; Mantovani, A; Morieri, M; Palmisano, L; Masulli, M; Cossu, E; Baroni, M; Bonomo, K; Cimini, F; Cavallo, G; Buzzetti, R; Mignogna, C; Leonetti, F; Bacci, S; Trevisan, R; Pollis, R; Aldigeri, R; Cas, A; de Kreutzenberg, S; Targher, G
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
2023 Mantovani, A; Morieri, M; Palmisano, L; Masulli, M; Cossu, E; Baroni, M; Bonomo, K; Cimini, F; Cavallo, G; Buzzetti, R; Mignogna, C; Leonetti, F; Bacci, S; Trevisan, R; Pollis, R; Aldigeri, R; Cas, A; de Kreutzenberg, S; Targher, G
The effect of Mindfulness therapy in acromegaly, a pilot study
2023 Santos, A; Nalin, C; Bortolotti, G; Dominguez-Clave, E; Daniela, G; Cortesi, L; Pagani, M; Momblan, M; Gich, I; Webb, S; Trevisan, R; Resmini, E
Uncertainties in cardiovascular risk factors: sodium-glucose cotransporter 2 inhibitors for all diabetic patients with high cardiovascular risk and in all patients with renal insufficiency, regardless of albuminuria? Glucagon-like peptide-1 receptor agonists as a weapon against obesity? [Incertezze nei fattori di rischio cardiovascolare: inibitori del cotrasportatore sodio-glucosio di tipo 2 per tutti i pazienti diabetici ad elevato rischio cardiovascolare e per tutti i pazienti con insufficienza renale indipendentemente dall’albuminuria? Agonisti del recettore del glucagon-like peptide-1 come arma contro l’obesità?]
2023 Avogaro, A; Corsini, A; Sinagra, G; Borghi, C; Sciatti, E; Trevisan, R; Fioretto, P; Calabrò, P; Di Pasquale, G; Senni, M
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
2023 Rosenstock, J; Bain, S; Gowda, A; Jódar, E; Liang, B; Lingvay, I; Nishida, T; Trevisan, R; Mosenzon, O
Does denosumab exert a protective effect against COVID-19? Results of a large cohort study
2023 Cassibba, S; Ippolito, S; Pellegrini, S; Trevisan, R; Rossini, A
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes
2023 Dei Cas, A; Aldigeri, R; Mantovani, A; Masulli, M; Palmisano, L; Cavalot, F; Bonomo, K; Baroni, M; Cossu, E; Cavallo, G; Cimini, F; Buzzetti, R; Mignogna, C; Leonetti, F; Bacci, S; Trevisan, R; Morieri, M; Pollis, R; Targher, G; Vigili de Kreutzenberg, S
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study
2023 Rossini, A; Cassibba, S; Perticone, F; Benatti, S; Venturelli, S; Carioli, G; Ghirardi, A; Rizzi, M; Barbui, T; Trevisan, R; Ippolito, S
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study
2022 Fadini, G; Buzzetti, R; Fittipaldi, M; D'Incau, F; Da Porto, A; Girelli, A; Simoni, L; Lastoria, G; Consoli, A; Iazzetta, N; Di Giovanni, G; Carbonara, O; Aragiusto, C; Carleo, D; Da Rosa, N; Martedi, E; Landolfi, L; Marracino, M; Tortora, A; De Morelli, G; Casarsa, V; Maddaloni, E; Siena, A; Pitocco, D; Tartaglione, L; Rizzi, A; Leonetti, F; Fasolo, M; Morsello, G; Bulzomi, R; Ruga, G; Bianconi, A; Torre, E; Rebora, A; Cecoli, F; Monti, E; Bonfadini, S; Dotti, S; Madaschi, S; Trevisan, R; Albizzi, M; Bellante, R; Corsi, A; Scaranna, C; De Cata, P; Liboa, F; Ghilotti, S; Tortato, E; Lanari, L; Turchi, F; Gabellieri, E; Lamacchia, O; Colucci, C; Mileti, G; Coluzzi, S; Carrieri, F; Rossetti, P; Anzaldi, M; Di Benedetto, A; Ruggeri, D; Scatena, A; Ranchelli, A; Ragusa, I; Gregori, G; Crisci, I; Mori, M; Baccetti, F; Anichini, R; Salutini, E; Vinci, C; Colletti, I; Zanon, M; Altomari, A; Bonora, B
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients
2022 Gori, M; Berzuini, C; D'Elia, E; Ghirardi, A; Bernardinelli, L; Gavazzi, A; Balestrieri, G; Giammarresi, A; Trevisan, R; Di Marco, F; Bellasi, A; Amoroso, M; Raimondi, F; Novelli, L; Magro, B; Mangia, G; Lorini, F; Guagliumi, G; Fagiuoli, S; Parati, G; Senni, M
Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
2022 Orsi, E; Solini, A; Bonora, E; Vitale, M; Garofolo, M; Fondelli, C; Trevisan, R; Vedovato, M; Cavalot, F; Laviola, L; Morano, S; Pugliese, G
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19
2022 Gori, M; Ghirardi, A; D'Elia, E; Imeri, G; Di Marco, F; Gavazzi, A; Carobbio, A; Balestrieri, G; Giammarresi, A; Trevisan, R; Amoroso, M; Raimondi, F; Novelli, L; Magro, B; Mangia, G; Lorini, F; Fagiuoli, S; Barbui, T; Rizzi, M; Cosentini, R; Sironi, S; Senni, M
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
2022 Orsi, E; Solini, A; Penno, G; Bonora, E; Fondelli, C; Trevisan, R; Vedovato, M; Cavalot, F; Lamacchia, O; Haxhi, J; Nicolucci, A; Pugliese, G
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial
2022 Carrara, F; Ruggenenti, P; Perna, A; Iliev, I; Gaspari, F; Ferrari, S; Stucchi, N; Bossi, A; Trevisan, R; Remuzzi, G; Parvanova, A
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)
2022 Ruggenenti, P; Cortinovis, M; Trillini, M; Parvanova, A; Abbate, M; Satriano, C; Salvetti, F; Bossi, A; Trevisan, R; Perna, A; Peracchi, T; Rubis, N; Diadei, O; Martinetti, D; Gaspari, F; Fontana, L; Remuzzi, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile